Sequences of monoclonal antiphospholipid antibodies: variations on an anti-DNA antibody theme (Q41209320)

28 September 2017

1 reference

title

Sequences of monoclonal antiphospholipid antibodies: variations on an anti-DNA antibody theme (English)

1 reference

28 September 2017

4

Isenberg DA

1 reference

28 September 2017

Rahman A

1

1 reference

PubMed ID

8916296

28 September 2017

Menon S

series ordinal

2

1 reference

PubMed ID

8916296

28 September 2017

Latchman DS

series ordinal

3

1 reference

28 September 2017

1 October 1996

1 reference

Seminars in Arthritis and Rheumatism

28 September 2017

1 reference

28 September 2017

26

1 reference

28 September 2017

2

1 reference

28 September 2017

515-525

1 reference

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

The origin, sequence, structure, and consequences of developing anti-DNA antibodies. A human perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Utilization of the VH4-21 Gene Segment by Anti-DNA Antibodies from Patients with Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

The human immunoglobulin VH repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

The role of clonal selection and somatic mutation in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Serological and genetic characterization of a human monoclonal immunoglobulin G anti-DNA idiotype

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

A natural autoantibody is encoded by germline heavy and lambda light chain variable region genes without somatic mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Early restriction of the human antibody repertoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Autoantibodies encoded by the most Jh-proximal human immunoglobulin heavy chain variable region gene

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Anti-DNA and anti-platelet specificities of SLE-derived autoantibodies: evidence for CDR2H mutations and CDR3H motifs.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

A human anti-cardiolipin autoantibody is encoded by developementally restricted heavy and light chain variable region genes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Somatic hypermutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Immunoglobulin V region sequences of two human antiplatelet monoclonal autoantibodies derived from B cells of normal origin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980040-0

7 January 2021

10.1016/S0049-0172(96)80040-0

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8916296